Credit: Shutterstock. A growing body of research shows SLT for first-line glaucoma therapy works as well as drops — so why aren’t clinician’s embracing it? Selective laser trabeculoplasty (SLT) was ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the Eagle device for selective laser trabeculoplasty. Laser energy is delivered in a noncontact ...

Please provide your email address to receive an email when new articles are posted on . Alcon completed the acquisition of Belkin Vision, including its direct selective laser trabeculoplasty ...

With the ongoing pandemic, ophthalmologists continue to search for new ways to reduce patient visits and possible virus exposure without sacrificing outcomes. Not surprisingly, monitoring and ...

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

SLT is emerging as a cost-effective first-line treatment, offering superior intraocular pressure stability compared to traditional eye drops. Minimally invasive glaucoma surgeries, like the iStent ...

Alcon has announced the US release of its Voyager direct selective laser trabeculoplasty (DSLT) platform, with a launch event scheduled for the American Glaucoma Society annual meeting later in ...

Before watching the video, approximately half (52%) of the physicians reported that their newly diagnosed patients receive laser therapy and only 47% said they would use it as first-line therapy for ...